Literature DB >> 29731811

Ethical Criteria for Human Challenge Studies in Infectious Diseases.

Ben Bambery1, Michael Selgelid1, Charles Weijer2, Julian Savulescu3, Andrew J Pollard3.   

Abstract

Purposeful infection of healthy volunteers with a microbial pathogen seems at odds with acceptable ethical standards, but is an important contemporary research avenue used to study infectious diseases and their treatments. Generally termed 'controlled human infection studies', this research is particularly useful for fast tracking the development of candidate vaccines and may provide unique insight into disease pathogenesis otherwise unavailable. However, scarce bioethical literature is currently available to assist researchers and research ethics committees in negotiating the distinct issues raised by research involving purposefully infecting healthy volunteers. In this article, we present two separate challenge studies and highlight the ethical issues of human challenge studies as seen through a well-constructed framework. Beyond the same stringent ethical standards seen in other areas of medical research, we conclude that human challenge studies should also include: (i) independent expert reviews, including systematic reviews; (ii) a publicly available rationale for the research; (iii) implementation of measures to protect the public from spread of infection beyond the research setting; and (iv) a new system for compensation for harm. We hope these additions may encourage safer and more ethical research practice and help to safeguard public confidence in this vital research alternative in years to come.

Entities:  

Year:  2015        PMID: 29731811      PMCID: PMC5926904          DOI: 10.1093/phe/phv026

Source DB:  PubMed          Journal:  Public Health Ethics        ISSN: 1754-9973            Impact factor:   1.940


  24 in total

1.  The ethical challenge of infection-inducing challenge experiments.

Authors:  F G Miller; C Grady
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  The hexamethonium asthma study and the death of a normal volunteer in research.

Authors:  J Savulescu; M Spriggs
Journal:  J Med Ethics       Date:  2002-02       Impact factor: 2.903

3.  Taking the plunge.

Authors:  J Savulescu
Journal:  New Sci       Date:  2001-03-03       Impact factor: 0.319

4.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; Solange Solmeheim Soulanoudjingar; José Francisco Fernandes; Béatrice Peggy Abossolo; Cornelia Conzelmann; Barbara Gaelle Nfono Ondo Methogo; Yannick Doucka; Arnaud Flamen; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Arlindo Nhamuave; Diana Quelhas; Quique Bassat; Sofia Mandjate; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Omar Juma; Mwanajaa Shomari; Kafuruki Shubis; Francisca Machera; Ali Said Hamad; Rose Minja; Ali Mtoro; Alma Sykes; Saumu Ahmed; Alwisa Martin Urassa; Ali Mohammed Ali; Grace Mwangoka; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Marc Christian Tahita; William Kaboré; Sayouba Ouédraogo; Yara Sandrine; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Chris Odero; Martina Oneko; Kephas Otieno; Norbert Awino; Jackton Omoto; John Williamson; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Otsyula Nekoye; Stacey Gondi; Allan Otieno; Bernhards Ogutu; Ruth Wasuna; Victorine Owira; David Jones; Agnes Akoth Onyango; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Jesse Gitaka; Charity Maingi; Trudie Lang; Ally Olotu; Benjamin Tsofa; Philip Bejon; Norbert Peshu; Kevin Marsh; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; Samuel Ayamba; Kingsley Kayan; Ruth Owusu-Ofori; David Dosoo; Isaac Asante; George Adjei; George Adjei; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Hassan Kilavo; Coline Mahende; Edwin Liheluka; Martha Lemnge; Thor Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Alex Agyekum; Larko Owusu; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Ruthendo Nkomo; Albans Msika; Allan Jumbe; Nelecy Chome; Dalitso Nyakuipa; Joseph Chintedza; W Ripley Ballou; Myriam Bruls; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Johan Vekemans; Terrell Carter; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2011-10-18       Impact factor: 91.245

5.  Payment of clinical research subjects.

Authors:  Christine Grady
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

Review 6.  Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!

Authors:  T K Mutabingwa
Journal:  Acta Trop       Date:  2005-09       Impact factor: 3.112

7.  Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139.

Authors:  M B Cohen; R A Giannella; G A Losonsky; D R Lang; S Parker; J A Hawkins; C Gunther; G A Schiff
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.

Authors:  L W Church; T P Le; J P Bryan; D M Gordon; R Edelman; L Fries; J R Davis; D A Herrington; D F Clyde; M J Shmuklarsky; I Schneider; T W McGovern; J D Chulay; W R Ballou; S L Hoffman
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

9.  New emerging drug-resistant malaria.

Authors:  Viroj Wiwanitkit
Journal:  Int J Gen Med       Date:  2010-10-11

10.  Challenge studies of human volunteers: ethical issues.

Authors:  T Hope; J McMillan
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

View more
  34 in total

Review 1.  The Kobe University Human Intestinal Microbiota Model for gut intervention studies.

Authors:  Namiko Hoshi; Jun Inoue; Daisuke Sasaki; Kengo Sasaki
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-15       Impact factor: 4.813

2.  Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Authors:  Jeffrey P Kahn; Leslie Meltzer Henry; Anna C Mastroianni; Wilbur H Chen; Ruth Macklin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

3.  Ethical challenges posed by human infection challenge studies in endemic settings.

Authors:  Michael J Selgelid; Euzebiusz Jamrozik
Journal:  Indian J Med Ethics       Date:  2018-09-18

4.  Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda.

Authors:  Moses Egesa; Agnes Ssali; Edward Tumwesige; Moses Kizza; Emmanuella Driciru; Fiona Luboga; Meta Roestenberg; Janet Seeley; Alison M Elliott
Journal:  Glob Bioeth       Date:  2022-07-04

5.  Ethical and Practical Issues Associated With the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus Vaccine.

Authors:  Andrea Cox; Mark Sulkowski; Jeremy Sugarman
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 20.999

6.  Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya.

Authors:  Maureen Njue; Patricia Njuguna; Melissa C Kapulu; Gladys Sanga; Philip Bejon; Vicki Marsh; Sassy Molyneux; Dorcas Kamuya
Journal:  Wellcome Open Res       Date:  2018-10-29

7.  Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials.

Authors:  Marie-Astrid Hoogerwerf; Martine de Vries; Meta Roestenberg
Journal:  BMJ Open       Date:  2020-07-26       Impact factor: 2.692

8.  Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

Authors:  Hu-Dachuan Jiang; Li Zhang; Jing-Xin Li; Feng-Cai Zhu
Journal:  Engineering (Beijing)       Date:  2021-05-19       Impact factor: 7.553

Review 9.  Challenges and Promise of a Hepatitis C Virus Vaccine.

Authors:  Andrea L Cox
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

10.  Exploring willingness to participate in future Human Infection Studies in Lusaka, Zambia: A nested qualitative exploratory study.

Authors:  Evelyn Muleba Kunda-Ngándu; Masuzyo Chirwa-Chobe; Chanda Mwamba; Jenala Chipungu; Esnart Ng'andu; Hope Mwanyungwi Chinganya; Michelo Simuyandi; Roma Chilengi; Anjali Sharma
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.